Yüklüyor......
Diabetes and gout: efficacy and safety of febuxostat and allopurinol
Aim Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. Methods Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month rando...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Blackwell Publishing Ltd
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902994/ https://ncbi.nlm.nih.gov/pubmed/23683134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12135 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|